- Home
- TKC vs ELAN Comparison
TKC vs ELAN Comparison
Compare TKC & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKC
- ELAN
- Stock Information
- Founded
- TKC 1993
- ELAN 1954
- Country
- TKC Turkey
- ELAN United States
- Employees
- TKC N/A
- ELAN N/A
- Industry
- TKC Telecommunications Equipment
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- TKC Telecommunications
- ELAN Health Care
- Exchange
- TKC Nasdaq
- ELAN Nasdaq
- Market Cap
- TKC 6.1B
- ELAN 5.4B
- IPO Year
- TKC 2000
- ELAN 2018
- Fundamental
- Price
- TKC $6.20
- ELAN $10.42
- Analyst Decision
- TKC
- ELAN Buy
- Analyst Count
- TKC 0
- ELAN 6
- Target Price
- TKC N/A
- ELAN $15.00
- AVG Volume (30 Days)
- TKC 827.6K
- ELAN 3.8M
- Earning Date
- TKC 05-27-2025
- ELAN 05-07-2025
- Dividend Yield
- TKC 3.29%
- ELAN N/A
- EPS Growth
- TKC 29.85
- ELAN N/A
- EPS
- TKC 0.30
- ELAN 0.68
- Revenue
- TKC $4,712,370,643.00
- ELAN $4,439,000,000.00
- Revenue This Year
- TKC $31.26
- ELAN $3.20
- Revenue Next Year
- TKC $26.69
- ELAN $4.26
- P/E Ratio
- TKC $8.26
- ELAN $15.12
- Revenue Growth
- TKC 7.77
- ELAN 0.50
- 52 Week Low
- TKC $5.10
- ELAN $10.03
- 52 Week High
- TKC $8.47
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- TKC 37.37
- ELAN 42.62
- Support Level
- TKC $6.08
- ELAN $10.45
- Resistance Level
- TKC $7.40
- ELAN $10.85
- Average True Range (ATR)
- TKC 0.19
- ELAN 0.36
- MACD
- TKC -0.10
- ELAN 0.03
- Stochastic Oscillator
- TKC 24.73
- ELAN 40.10
About TKC Turkcell Iletisim Hizmetleri AS
Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, Netherlands, and Ukraine. It has three main reportable segments, Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment that derives the majority of revenue comprises mainly telecommunication and technology services activities.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.